Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ketamine composition for use in a method of treatment of depression by pulmonary administration

Ketamine composition for use in a method of treatment of depression by pulmonary administration

US Patent 11925607 · Granted Mar 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dry powder esketamine composition for use in the treatment of bipolar depression2025
3-phenyl-4-hexynoic acid derivatives as GPR40 agonists2024
Inhaler2021
Pyrazole[1,5-a] pyrimidine derivatives as kinase JAK inhibitors2021
Fused triazole derivatives as phosphodiesterase 10A inhibitors2018
Fused triazole derivatives as phosphodiesterase 10A inhibitors2018
7-(morpholin-4-yl)pyrazole[1,5-A]pyrimidine derivatives as PI3 kinase inhibitors2018
Inhaler2018
Pyrazolylbenzo[d]imidazole derivatives2017
Inhaler2017
Label for an inhaler2016
Label for an inhaler2015